• Issues
    • Current Issue
    • Special Issues
  • Viewpoints
    • Editor’s Corner
    • Advanced Practice Voices
    • From Our Readers
      • You Make the Call: Readers’ Response
      • Guest Commentary
      • Letters to the Editor
    • A Day in the Life
    • Notes From the Hill
    • The Break Room
  • Education
    • You Make the Call
    • How I Teach
    • How I Treat In Brief
    • Demystifying the Lab
    • Practice Update
  • Spotlight
    • Feature Articles
    • Pulling Back the Curtain
    • Blood Beyond Borders
    • pASHions
    • Drawing First Blood
    • Interviews
  • News
    • Online Exclusives
    • Latest & Greatest
    • From the Blood Journals
      • Written in Blood
      • Blood Advances in a Different Vein
    • Literature Scan
    • ASH Directions
    • The Society Pages
  • Topic Compilations
    • COVID-19 News
    • Acute Leukemias
    • Chronic Leukemias
    • MDS & Myeloproliferative Neoplasms
    • Multiple Myeloma & Plasma Cell Disorders
    • Lymphomas & Lymphoid Neoplasia
    • Bleeding Disorders
    • Clotting Disorders
    • Red Blood Cell & Iron Disorders
  • On Location
    • ASH Annual Meeting
    • ASH Meeting on Hematologic Malignancies
    • ASH Meeting on Lymphoma Biology
    • Other Meetings
  • Multimedia
    • Sound Bites
    • Meeting Coverage
Search
  • ASH Home
  • About ASH Clinical News
  • Authors
  • Advertising
  • Subscribe
  • Contact Us
  • eNewsletters
  • Cookie Settings
  • LOG IN
Welcome! Log into your account
Forgot your password?
Recover your password
ASH Clinical News
  • Issues
    • AllCurrent IssueSpecial Issues

      January 2021 Annual Meeting Edition

      January 2021 Volume 7 Issue 1

      December 2020, Volume 6, Issue 15

      November 2020 Bonus ASH Annual Meeting Preview Edition (Volume 6, Issue…

  • Viewpoints
    • Editor’s Corner
    • Advanced Practice Voices
    • From Our Readers
      • You Make the Call: Readers’ Response
      • Guest Commentary
      • Letters to the Editor
    • A Day in the Life
    • Notes From the Hill
    • The Break Room
  • Education
    • You Make the Call
    • How I Teach
    • How I Treat In Brief
    • Demystifying the Lab
    • Practice Update
  • Spotlight
    • Feature Articles
    • Pulling Back the Curtain
    • Blood Beyond Borders
    • pASHions
    • Drawing First Blood
    • Interviews
  • News
    • Online Exclusives
    • Latest & Greatest
    • From the Blood Journals
      • Written in Blood
      • Blood Advances in a Different Vein
    • Literature Scan
    • ASH Directions
    • The Society Pages
  • Topic Compilations
    • COVID-19 News
    • Acute Leukemias
    • Chronic Leukemias
    • MDS & Myeloproliferative Neoplasms
    • Multiple Myeloma & Plasma Cell Disorders
    • Lymphomas & Lymphoid Neoplasia
    • Bleeding Disorders
    • Clotting Disorders
    • Red Blood Cell & Iron Disorders
  • On Location
    • ASH Annual Meeting
    • ASH Meeting on Hematologic Malignancies
    • ASH Meeting on Lymphoma Biology
    • Other Meetings
  • Multimedia
    • Sound Bites
    • Meeting Coverage
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Home Multimedia
  • Multimedia
  • Sound Bites

Pulling Back the Curtain: Donna DiMichele, MD

Friday, October 27, 2017

In more from her Pulling Back the Curtain interview, Donna DiMichele, MD, tells us about her childhood in Montreal, Canada, and reflects on how hematology has changed since she started her career.

SHARE
ajones
Advertisement

Recent Articles

January 2021 Annual Meeting Edition

Friday, January 15, 2021
This issue features highlights from the 2020 ASH Annual Meeting, a look at patient holiday gift customs around the world, and more.

FDA Approves Ponatinib for Chronic-Phase CML

Friday, January 15, 2021
The U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application for ponatinib to treat adults with chronic-phase chronic myeloid leukemia...

Large Meta-Analysis Confirms Predictive Value of MRD Negativity in Myeloma

Friday, January 15, 2021
Achievement of measurable residual disease (MRD) negativity is associated with significant improvements in progression-free survival (PFS) and overall survival (OS) in patients with multiple...

Selinexor Combination Approved for Patients with Multiple Myeloma

Friday, January 15, 2021
The FDA has approved selinexor in combination with bortezomib and dexamethasone (Vd) for the treatment of adults with multiple myeloma (MM) who have received...
On location

Big Ideas on Burnout: Trainees Propose System-Wide Solutions

Friday, January 15, 2021
The Special Symposium on Quality at the 2020 ASH Annual Meeting tackled an often-overlooked driver of quality of patient care: burnout. Physician burnout –...

Current Issue

January 2021 Annual Meeting Edition

Friday, January 15, 2021
This issue features highlights from the 2020 ASH Annual Meeting, a look at patient holiday gift customs around the world, and more.
Related Articles
Recent Posts
  • FDA Approves Ponatinib for Chronic-Phase CML
  • Large Meta-Analysis Confirms Predictive Value of MRD Negativity in Myeloma
  • Selinexor Combination Approved for Patients with Multiple Myeloma
  • Big Ideas on Burnout: Trainees Propose System-Wide Solutions

Meeting Coverage

MLL Associated With Worse Post-Transplant Outcomes Than Other Cytogenetic Factors

Friday, May 1, 2020

Study Examines Trends in Real-World Treatment Sequencing Patterns for CLL/SLL

Sunday, March 1, 2020

Editor's Corner

There’s No Crime Like the Presents

Friday, January 15, 2021

Musical and Medical Reflections

Friday, January 1, 2021
2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545
  • ASH Home
  • Research
  • Education
  • Advocacy
  • Meetings
  • Publications
  • ASH Store
Copyright © 2020 by American Society of Hematology

Contact Us | Terms of Service | Privacy Policy